Literature DB >> 14627732

Accommodation of a highly symmetric core within a symmetric protein superfold.

Stephen R Brych1, Jaewon Kim, Timothy M Logan, Michael Blaber.   

Abstract

An alternative core packing group, involving a set of five positions, has been introduced into human acidic FGF-1. This alternative group was designed so as to constrain the primary structure within the core region to the same threefold symmetry present in the tertiary structure of the protein fold (the beta-trefoil superfold). The alternative core is essentially indistinguishable from the WT core with regard to structure, stability, and folding kinetics. The results show that the beta-trefoil superfold is compatible with a threefold symmetric constraint on the core region, as might be the case if the superfold arose as a result of gene duplication/fusion events. Furthermore, this new core arrangement can form the basis of a structural "building block" that can greatly simplify the de novo design of beta-trefoil proteins by using symmetric structural complementarity. Remaining asymmetry within the core appears to be related to asymmetry in the tertiary structure associated with receptor and heparin binding functionality of the growth factor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14627732      PMCID: PMC2366980          DOI: 10.1110/ps.03374903

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  68 in total

1.  X-ray crystal structure of human acidic fibroblast growth factor.

Authors:  M Blaber; J DiSalvo; K A Thomas
Journal:  Biochemistry       Date:  1996-02-20       Impact factor: 3.162

2.  Crystal structure of botulinum neurotoxin type A and implications for toxicity.

Authors:  D B Lacy; W Tepp; A C Cohen; B R DasGupta; R C Stevens
Journal:  Nat Struct Biol       Date:  1998-10

3.  The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding.

Authors:  L S Itzhaki; D E Otzen; A R Fersht
Journal:  J Mol Biol       Date:  1995-11-24       Impact factor: 5.469

4.  Crystal structure of abrin-a at 2.14 A.

Authors:  T H Tahirov; T H Lu; Y C Liaw; Y L Chen; J Y Lin
Journal:  J Mol Biol       Date:  1995-07-14       Impact factor: 5.469

Review 5.  Protein design: a hierarchic approach.

Authors:  J W Bryson; S F Betz; H S Lu; D J Suich; H X Zhou; K T O'Neil; W F DeGrado
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

6.  Protein superfamilies and domain superfolds.

Authors:  C A Orengo; D T Jones; J M Thornton
Journal:  Nature       Date:  1994-12-15       Impact factor: 49.962

7.  De novo design of native proteins: characterization of proteins intended to fold into antiparallel, rop-like, four-helix bundles.

Authors:  S F Betz; P A Liebman; W F DeGrado
Journal:  Biochemistry       Date:  1997-03-04       Impact factor: 3.162

8.  Engineering of fibroblast growth factor: alteration of receptor binding specificity.

Authors:  A P Seddon; D Aviezer; L Y Li; P Böhlen; A Yayon
Journal:  Biochemistry       Date:  1995-01-24       Impact factor: 3.162

9.  Barley alpha-amylase bound to its endogenous protein inhibitor BASI: crystal structure of the complex at 1.9 A resolution.

Authors:  F Vallée; A Kadziola; Y Bourne; M Juy; K W Rodenburg; B Svensson; R Haser
Journal:  Structure       Date:  1998-05-15       Impact factor: 5.006

10.  Controlling topology and native-like behavior of de novo-designed peptides: design and characterization of antiparallel four-stranded coiled coils.

Authors:  S F Betz; W F DeGrado
Journal:  Biochemistry       Date:  1996-05-28       Impact factor: 3.162

View more
  10 in total

1.  Experimental support for the evolution of symmetric protein architecture from a simple peptide motif.

Authors:  Jihun Lee; Michael Blaber
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

2.  Redesigning symmetry-related "mini-core" regions of FGF-1 to increase primary structure symmetry: thermodynamic and functional consequences of structural symmetry.

Authors:  Vikash Kumar Dubey; Jihun Lee; Michael Blaber
Journal:  Protein Sci       Date:  2005-08-04       Impact factor: 6.725

Review 3.  Emergence of symmetric protein architecture from a simple peptide motif: evolutionary models.

Authors:  Michael Blaber; Jihun Lee; Liam Longo
Journal:  Cell Mol Life Sci       Date:  2012-07-13       Impact factor: 9.261

4.  Engineering a Cysteine-Free Form of Human Fibroblast Growth Factor-1 for "Second Generation" Therapeutic Application.

Authors:  Xue Xia; Ozan S Kumru; Sachiko I Blaber; C Russell Middaugh; Ling Li; David M Ornitz; Mason A Sutherland; Connie A Tenorio; Michael Blaber
Journal:  J Pharm Sci       Date:  2016-04       Impact factor: 3.534

5.  Exploring symmetry as an avenue to the computational design of large protein domains.

Authors:  Carie Fortenberry; Elizabeth Anne Bowman; Will Proffitt; Brent Dorr; Steven Combs; Joel Harp; Laura Mizoue; Jens Meiler
Journal:  J Am Chem Soc       Date:  2011-10-21       Impact factor: 15.419

6.  Experimental support for the foldability-function tradeoff hypothesis: segregation of the folding nucleus and functional regions in fibroblast growth factor-1.

Authors:  Liam Longo; Jihun Lee; Michael Blaber
Journal:  Protein Sci       Date:  2012-11-06       Impact factor: 6.725

7.  X-ray structure and biophysical properties of rabbit fibroblast growth factor 1.

Authors:  Jihun Lee; Sachiko I Blaber; Andre Irsigler; Eric Aspinwall; Michael Blaber
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-10-30

8.  Identification and Analysis of Long Repeats of Proteins at the Domain Level.

Authors:  David Mary Rajathei; Subbiah Parthasarathy; Samuel Selvaraj
Journal:  Front Bioeng Biotechnol       Date:  2019-10-08

9.  Cooperative hydrophobic core interactions in the β-trefoil architecture.

Authors:  Michael Blaber
Journal:  Protein Sci       Date:  2021-03-16       Impact factor: 6.725

10.  Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application.

Authors:  Xue Xia; Joseph P Babcock; Sachiko I Blaber; Kathleen M Harper; Michael Blaber
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.